Homologous or heterogenous vaccination boosters enhance neutralizing activities against SARS‐CoV‐2 Omicron BA.1 variant.

Published in:

MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.143

By:

• Zhou, Zhongcheng;
• Du, Peng;
• Li, Ning;
• Xiong, Xinxin;
• Tang, Shengjun;
• Dai, Qinjin;
• Wang, Taorui;
• Yu, Meixing;
• Man, Miao;
• Lam, Kelvin;
• Baptista‐Hon, Daniel T.;
• Tai, Wa Hou;
• Monteiro, Olivia;
• Ng, Weng Sam;
• Lee, Un Man;
• Liu, Zhihai;
• Zhang, Kang;
• Li, Gen

Publication type:

Article